研究发现,digoxin通过分解癌症细胞群,可以减少乳腺癌的转移。 Study finds digoxin may reduce breast cancer metastasis by breaking apart cancer cell clusters.

来自苏黎世ETH和瑞士各医院的研究人员发现,Digoxin作为一种传统上用于心脏病的药物,可以减少乳腺癌患者的癌症细胞群的规模,并有可能降低转移转移风险。 Researchers from ETH Zurich and hospitals in Switzerland have found that digoxin, a drug traditionally used for heart conditions, can reduce the size of cancer cell clusters in breast cancer patients, potentially lowering metastasis risk. 这种药物削弱了癌症细胞的钠-钾泵,导致聚类分解,尽管它并不消除现有的肿瘤。 The drug weakens the cancer cells' sodium-potassium pumps, causing the clusters to break apart, though it does not eliminate existing tumors. 这一突破在《自然医学》中发表,可能导致新的转移性癌症治疗,并计划对其他类型的癌症进行进一步研究。 This breakthrough, published in Nature Medicine, could lead to new treatments for metastatic cancer, with further research planned for other types of cancer.